A bioengineer highlights the potential of low-intensity ultrasound for multiple uses, from enhanced drug delivery to the ...

The platform features Healthgrades, a tool intended to connect Alzheimer's patients to experienced local clinicians.

The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the risk of serious brain ...

As we wait for a breakthrough that can block or reverse Alzheimer’s disease, there is some consolation that we finally have three kinds of medications and a treatment that can ...

Ask most health professionals what you can do to prevent or delay dementia, and you will likely be told to maintain a healthy diet, exercise regularly, control your blood pressure, blood sugar and ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Crosswords and sardines are great, but there are other ways to stay sharp into old age. And it’s never too early to start.

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 ...

The company said its goal is to reduce wait times for patients seeking access to specialists, creating more opportunities for ...

Topline results were announced from a phase 3 trial evaluating simufilam, an oral small molecule that targets the filamin A protein, for the treatment of mild to moderate Alzheimer disease (AD).